Warsaw, Ind.-based Zimmer Biomet and CD Diagnostics first partnered in 2012 to develop and market diagnostics for the musculoskeletal healthcare market.
“We’re excited to team up with CD Diagnostics to accelerate the pace of innovation in musculoskeletal diagnostics, ramp up adoption of testing into standard protocols, and arm surgeons with critical data to inform diagnosis, staging, treatment and recovery,” said Dan Williamson, group president of joint reconstruction for Zimmer Biomet.
Financial terms of the transaction were not disclosed.
More articles on supply chain:
Medline, Community Health Ventures enter group purchasing partnership
FDA approves Boston Scientific’s implantable defibrillator
FDA grants priority review status to muscular dystrophy drug
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
